Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insecticides | 13 | 2022 | 45 | 5.460 |
Why?
|
| Permethrin | 7 | 2019 | 10 | 3.650 |
Why?
|
| Adipogenesis | 9 | 2019 | 81 | 3.450 |
Why?
|
| Linoleic Acids, Conjugated | 10 | 2018 | 13 | 3.150 |
Why?
|
| Adipocytes | 9 | 2019 | 274 | 3.030 |
Why?
|
| Caenorhabditis elegans | 10 | 2021 | 703 | 2.900 |
Why?
|
| Triglycerides | 10 | 2019 | 248 | 2.400 |
Why?
|
| Obesity | 7 | 2022 | 1272 | 1.550 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2021 | 444 | 1.420 |
Why?
|
| Fats | 3 | 2019 | 20 | 1.240 |
Why?
|
| Ivermectin | 2 | 2019 | 25 | 1.170 |
Why?
|
| Insulin Resistance | 3 | 2017 | 415 | 1.160 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 224 | 1.160 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2017 | 83 | 1.090 |
Why?
|
| Energy Metabolism | 4 | 2019 | 400 | 1.040 |
Why?
|
| Hepatocytes | 2 | 2019 | 222 | 1.020 |
Why?
|
| Animals | 30 | 2022 | 21356 | 0.990 |
Why?
|
| 3T3-L1 Cells | 8 | 2019 | 90 | 0.890 |
Why?
|
| Plant Extracts | 2 | 2019 | 130 | 0.890 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 98 | 0.890 |
Why?
|
| Signal Transduction | 5 | 2021 | 3148 | 0.800 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2019 | 52 | 0.800 |
Why?
|
| Nitriles | 3 | 2019 | 82 | 0.770 |
Why?
|
| Lipids | 2 | 2016 | 327 | 0.770 |
Why?
|
| Models, Animal | 3 | 2019 | 242 | 0.760 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 733 | 0.740 |
Why?
|
| PPAR gamma | 3 | 2019 | 77 | 0.730 |
Why?
|
| Adipose Tissue | 4 | 2019 | 300 | 0.730 |
Why?
|
| Muscle, Skeletal | 3 | 2016 | 787 | 0.730 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 151 | 0.700 |
Why?
|
| Pyruvaldehyde | 1 | 2021 | 6 | 0.680 |
Why?
|
| Mice | 17 | 2019 | 11125 | 0.680 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2018 | 80 | 0.670 |
Why?
|
| Cell Differentiation | 5 | 2019 | 1382 | 0.670 |
Why?
|
| Pyrethrins | 2 | 2019 | 9 | 0.660 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 97 | 0.650 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 10 | 0.650 |
Why?
|
| Sulfonic Acids | 1 | 2020 | 11 | 0.650 |
Why?
|
| Emulsions | 3 | 2019 | 497 | 0.640 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 1630 | 0.630 |
Why?
|
| Fluorocarbons | 1 | 2020 | 51 | 0.620 |
Why?
|
| Diterpenes | 1 | 2019 | 13 | 0.610 |
Why?
|
| Glucose | 3 | 2017 | 478 | 0.610 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 9 | 0.600 |
Why?
|
| Fatty Acid Desaturases | 1 | 2019 | 9 | 0.600 |
Why?
|
| Environmental Exposure | 2 | 2022 | 226 | 0.600 |
Why?
|
| Antiparasitic Agents | 1 | 2019 | 10 | 0.600 |
Why?
|
| Dietary Supplements | 3 | 2019 | 236 | 0.590 |
Why?
|
| Cell Membrane | 1 | 2022 | 506 | 0.580 |
Why?
|
| Lipogenesis | 1 | 2019 | 66 | 0.550 |
Why?
|
| Dietary Fats | 2 | 2017 | 180 | 0.540 |
Why?
|
| Curcumin | 1 | 2019 | 82 | 0.530 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2017 | 42 | 0.530 |
Why?
|
| Food | 1 | 2017 | 76 | 0.510 |
Why?
|
| Body Weight | 5 | 2017 | 376 | 0.510 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 213 | 0.510 |
Why?
|
| Particle Size | 1 | 2019 | 430 | 0.510 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 235 | 0.500 |
Why?
|
| Drug Carriers | 1 | 2019 | 189 | 0.500 |
Why?
|
| Performance-Enhancing Substances | 1 | 2016 | 1 | 0.500 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 180 | 0.490 |
Why?
|
| Body Composition | 4 | 2016 | 155 | 0.480 |
Why?
|
| Physical Endurance | 1 | 2016 | 48 | 0.480 |
Why?
|
| Drug Delivery Systems | 2 | 2019 | 332 | 0.480 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 216 | 0.480 |
Why?
|
| DDT | 1 | 2016 | 2 | 0.480 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2016 | 4 | 0.480 |
Why?
|
| Potassium Chloride | 1 | 2015 | 15 | 0.470 |
Why?
|
| Polysorbates | 1 | 2015 | 43 | 0.460 |
Why?
|
| Functional Food | 1 | 2016 | 39 | 0.460 |
Why?
|
| Sodium Chloride | 1 | 2015 | 65 | 0.460 |
Why?
|
| Pyrazoles | 1 | 2016 | 88 | 0.460 |
Why?
|
| Aging | 2 | 2017 | 773 | 0.430 |
Why?
|
| Motor Activity | 1 | 2017 | 346 | 0.430 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2012 | 21 | 0.430 |
Why?
|
| Vaccinium macrocarpon | 1 | 2014 | 5 | 0.420 |
Why?
|
| Dextran Sulfate | 1 | 2014 | 39 | 0.420 |
Why?
|
| Calcium | 1 | 2017 | 584 | 0.410 |
Why?
|
| Insulin | 1 | 2017 | 696 | 0.400 |
Why?
|
| Nanoparticles | 2 | 2019 | 546 | 0.400 |
Why?
|
| Colitis | 1 | 2014 | 77 | 0.390 |
Why?
|
| Transcription Factors | 1 | 2021 | 1555 | 0.380 |
Why?
|
| Nitro Compounds | 1 | 2012 | 15 | 0.380 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 110 | 0.370 |
Why?
|
| Imidazoles | 1 | 2012 | 82 | 0.370 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2012 | 28 | 0.360 |
Why?
|
| Health Promotion | 1 | 2016 | 522 | 0.330 |
Why?
|
| Movement | 1 | 2012 | 164 | 0.330 |
Why?
|
| Phosphorylation | 3 | 2018 | 961 | 0.330 |
Why?
|
| Random Allocation | 4 | 2016 | 200 | 0.320 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 765 | 0.320 |
Why?
|
| Homeostasis | 3 | 2017 | 378 | 0.310 |
Why?
|
| Membrane Potentials | 2 | 2022 | 140 | 0.310 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 28 | 0.290 |
Why?
|
| Calcium, Dietary | 1 | 2008 | 28 | 0.280 |
Why?
|
| Locomotion | 2 | 2021 | 111 | 0.280 |
Why?
|
| Diet | 4 | 2016 | 536 | 0.270 |
Why?
|
| Anti-Obesity Agents | 1 | 2007 | 16 | 0.260 |
Why?
|
| Bone Density | 1 | 2008 | 142 | 0.260 |
Why?
|
| Acetyl-CoA Carboxylase | 2 | 2017 | 16 | 0.250 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2018 | 211 | 0.240 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 328 | 0.240 |
Why?
|
| Fatty Liver | 2 | 2019 | 110 | 0.240 |
Why?
|
| Energy Intake | 2 | 2017 | 173 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 857 | 0.240 |
Why?
|
| Immunoblotting | 2 | 2016 | 202 | 0.230 |
Why?
|
| Mice, Inbred ICR | 3 | 2012 | 33 | 0.230 |
Why?
|
| Eicosanoic Acids | 1 | 2005 | 3 | 0.220 |
Why?
|
| Anticarcinogenic Agents | 1 | 2005 | 33 | 0.220 |
Why?
|
| Male | 8 | 2020 | 31147 | 0.180 |
Why?
|
| Humans | 9 | 2022 | 65385 | 0.180 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1575 | 0.170 |
Why?
|
| Body Size | 1 | 2021 | 19 | 0.170 |
Why?
|
| Eating | 3 | 2007 | 140 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3483 | 0.160 |
Why?
|
| Reproduction | 1 | 2020 | 99 | 0.150 |
Why?
|
| Enoyl-CoA Hydratase | 1 | 2019 | 2 | 0.150 |
Why?
|
| Biomarkers | 2 | 2016 | 1474 | 0.150 |
Why?
|
| Receptors, Glycine | 1 | 2019 | 9 | 0.150 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 18 | 0.150 |
Why?
|
| Palmitic Acid | 1 | 2019 | 14 | 0.150 |
Why?
|
| Fish Oils | 1 | 2019 | 43 | 0.140 |
Why?
|
| Corn Oil | 1 | 2019 | 51 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2016 | 502 | 0.140 |
Why?
|
| Butadienes | 1 | 2018 | 14 | 0.140 |
Why?
|
| Whey Proteins | 1 | 2019 | 70 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 129 | 0.140 |
Why?
|
| Biological Availability | 1 | 2019 | 208 | 0.140 |
Why?
|
| Linoleic Acid | 1 | 2018 | 19 | 0.140 |
Why?
|
| Emulsifying Agents | 1 | 2019 | 83 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2019 | 199 | 0.130 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2017 | 60 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 28 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 198 | 0.130 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2016 | 5 | 0.120 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 41 | 0.120 |
Why?
|
| Mitochondrial Dynamics | 1 | 2016 | 13 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2016 | 24 | 0.120 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 21 | 0.120 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2016 | 36 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 1 | 2017 | 175 | 0.120 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 27 | 0.120 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2016 | 16 | 0.120 |
Why?
|
| Ribonucleotides | 1 | 2016 | 19 | 0.120 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2016 | 14 | 0.120 |
Why?
|
| Isomerism | 1 | 2016 | 29 | 0.120 |
Why?
|
| Edetic Acid | 1 | 2015 | 24 | 0.120 |
Why?
|
| Gene Expression | 1 | 2019 | 854 | 0.120 |
Why?
|
| 3T3 Cells | 1 | 2016 | 111 | 0.120 |
Why?
|
| Adiposity | 1 | 2016 | 89 | 0.120 |
Why?
|
| Proteomics | 1 | 2018 | 294 | 0.110 |
Why?
|
| Milk | 1 | 2016 | 47 | 0.110 |
Why?
|
| Weight Gain | 1 | 2016 | 165 | 0.110 |
Why?
|
| Immunity | 1 | 2016 | 107 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 542 | 0.110 |
Why?
|
| Female | 5 | 2020 | 34146 | 0.100 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 168 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2016 | 161 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2016 | 317 | 0.100 |
Why?
|
| Neonicotinoids | 1 | 2012 | 1 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 461 | 0.090 |
Why?
|
| Mutation | 1 | 2021 | 2665 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2187 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 643 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2007 | 606 | 0.060 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2005 | 1 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2005 | 58 | 0.060 |
Why?
|
| Microsomes, Liver | 1 | 2005 | 16 | 0.060 |
Why?
|
| Proteinuria | 1 | 2005 | 41 | 0.060 |
Why?
|
| Lipoprotein Lipase | 1 | 2005 | 13 | 0.060 |
Why?
|
| Glycerol | 1 | 2005 | 34 | 0.060 |
Why?
|
| Organ Size | 1 | 2005 | 173 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 68 | 0.050 |
Why?
|
| Longevity | 1 | 2005 | 117 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2005 | 370 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 454 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2005 | 742 | 0.040 |
Why?
|
| Rats | 1 | 2005 | 1995 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2024 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2304 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2019 | 391 | 0.040 |
Why?
|